Our Investment Criteria

• Rapidly Growing Market: We pursue companies that operate in large, rapidly-growing or transforming markets. The typical markets we pursue are experiencing dramatic changes because of new technologies or regulations, or changing customer sentiment.

• Clear Product or Service Need: We invest in companies developing products or services that address clear inefficiencies or needs in the market. These incrementally novel approaches often require less time and capital to be successful, and can capture significant value through management’s ability to balance vision with speed and superior execution.

• Capital Efficient Business Model: Capital efficiency and the ability to harness global resources are two important characteristics of each investment in our portfolio. Across the Business Services and Healthcare/Life Sciences sectors, we seek investment opportunities that can scale quickly with a reasonable amount of capital investment.

• Strong Management: The quality of a company’s management team is a critical factor in determining the overall success of the business. We leverage our human capital network and advisory relationships to play an active role in helping attract additional top-tier talent.

• Early and Expansion Stage: We invest in early- and expansion-stage companies. Early-stage companies typically have established proof-of-concept for their technology or service, and often have a senior executive in place who is an experienced leader in his/her field. Expansion-stage companies typically have generated meaningful revenues (for Business Services companies), or substantial clinical data or FDA approval (for Life Sciences companies).